Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2023 Sep;57(9):1118-1119.
doi: 10.1177/10600280221144936. Epub 2022 Dec 28.

Reply: Baricitinib Versus Tocilizumab for the Treatment of Moderate to Severe COVID-19

Temeka Dawn Lewis-Wolfson, Kayla Rena Joyner
Comment

Reply: Baricitinib Versus Tocilizumab for the Treatment of Moderate to Severe COVID-19

Temeka Dawn Lewis-Wolfson et al. Ann Pharmacother. 2023 Sep.
No abstract available

PubMed Disclaimer

Comment on

References

    1. Reid NK, Joyner KR, Lewis-Wolfson TD. Baricitinib versus tocilizumab for the treatment of moderate to severe COVID-19 [published online ahead of print October 29, 2022]. Ann Pharmacother. doi:10.1177/10600280221133376 - DOI - PMC - PubMed
    1. Hill JB, Garcia D, Crowther M, et al.. Frequency of venous thromboembolism in 6513 patients with COVID-19: a retrospective study. Blood Adv. 2020;4:5373-5377. doi:10.1182/bloodadvances.2020003083 - DOI - PMC - PubMed
    1. COVID-19 Treatment Guidelines Panel. Coronavirus disease 2019 (COVID-19) treatment guidelines. National Institutes of Health. Date unknown. Accessed November 11, 2022. https://www.covid19treatmentguidelines.nih.gov/ - PubMed
    1. REMAP-CAP Investigators, Gordon AC, Mouncey PR, et al.. Interleukin-6 receptor antagonists in critically ill patients with COVID-19. N Engl J Med. 2021;384(16):1491-1502. - PMC - PubMed
    1. RECOVERY Collaborative Group. Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Lancet. 2021;397(10285):1637-1645. - PMC - PubMed